NCT01619527View on ClinicalTrials.gov

A Study to Assess the Bioequivalence of Darunavir When Co-Administrated With Cobicistat Under Fed and Fasted Conditions

PHASE1CompletedINTERVENTIONAL

Enrollment

133

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

August 31, 2012

Study Completion Date

August 31, 2012

Conditions

Healthy Participants

Interventions

DRUG

darunavir

Type=exact number, unit=mg, number=400, form=tablet, route=oral. Two tablets as a single dose or a tablet in combination with cobicistat

DRUG

cobicistat

Type=exact number, unit=mg, number=150, form=tablet, route=oral. One tablet as a single dose or a tablet in combination with darunavir

Trial Locations (1)

Unknown

Merksem

All Listed Sponsors

lead

Janssen R&D Ireland

INDUSTRY

NCT01619527 - A Study to Assess the Bioequivalence of Darunavir When Co-Administrated With Cobicistat Under Fed and Fasted Conditions | Biotech Hunter | Biotech Hunter